FADINI, GIAN PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.960
AS - Asia 8.884
EU - Europa 6.764
AF - Africa 2.527
SA - Sud America 2.123
OC - Oceania 273
Continente sconosciuto - Info sul continente non disponibili 130
Totale 48.661
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.679
SG - Singapore 2.542
CN - Cina 1.970
HK - Hong Kong 1.462
BR - Brasile 1.344
IT - Italia 1.271
DE - Germania 684
FI - Finlandia 609
VN - Vietnam 467
SE - Svezia 447
PL - Polonia 358
GB - Regno Unito 336
FR - Francia 327
RU - Federazione Russa 265
UA - Ucraina 248
NL - Olanda 221
IN - India 191
IE - Irlanda 150
AR - Argentina 136
MX - Messico 131
CI - Costa d'Avorio 128
TR - Turchia 124
IQ - Iraq 118
ES - Italia 105
AT - Austria 102
EC - Ecuador 100
ZA - Sudafrica 99
KR - Corea 96
AE - Emirati Arabi Uniti 88
PE - Perù 87
CO - Colombia 84
AL - Albania 82
BE - Belgio 82
GR - Grecia 81
JP - Giappone 81
MA - Marocco 80
PY - Paraguay 80
AO - Angola 79
CA - Canada 79
GA - Gabon 79
SA - Arabia Saudita 79
PA - Panama 78
NI - Nicaragua 77
VE - Venezuela 76
CR - Costa Rica 75
CH - Svizzera 74
DZ - Algeria 74
IL - Israele 74
MK - Macedonia 74
TN - Tunisia 74
KZ - Kazakistan 72
AZ - Azerbaigian 71
BG - Bulgaria 71
ID - Indonesia 71
SN - Senegal 71
EG - Egitto 70
GH - Ghana 70
PH - Filippine 70
CV - Capo Verde 69
CZ - Repubblica Ceca 69
IR - Iran 69
KE - Kenya 69
LB - Libano 68
SK - Slovacchia (Repubblica Slovacca) 68
AM - Armenia 67
JM - Giamaica 67
JO - Giordania 67
MD - Moldavia 67
RS - Serbia 67
EE - Estonia 66
LV - Lettonia 66
NZ - Nuova Zelanda 66
KH - Cambogia 65
MY - Malesia 65
DJ - Gibuti 64
GT - Guatemala 64
KG - Kirghizistan 64
ML - Mali 64
RO - Romania 64
UG - Uganda 64
UZ - Uzbekistan 64
DK - Danimarca 63
LU - Lussemburgo 63
TW - Taiwan 63
CD - Congo 62
HU - Ungheria 62
IS - Islanda 62
LA - Repubblica Popolare Democratica del Laos 62
MR - Mauritania 62
NO - Norvegia 62
PR - Porto Rico 62
PT - Portogallo 62
UY - Uruguay 62
BJ - Benin 61
BS - Bahamas 61
CM - Camerun 61
PS - Palestinian Territory 61
TH - Thailandia 61
BY - Bielorussia 60
CW - ???statistics.table.value.countryCode.CW??? 60
Totale 45.708
Salva come PNG Salva come JPEG
Città #
Fairfield 4.268
Woodbridge 2.549
Ashburn 2.302
Houston 2.238
Ann Arbor 1.767
Chandler 1.691
Seattle 1.562
Singapore 1.534
Cambridge 1.492
Hong Kong 1.391
Wilmington 1.333
Jacksonville 680
Boardman 559
Beijing 553
Princeton 462
San Diego 422
Santa Clara 420
Roxbury 311
Medford 273
Padova 252
Helsinki 249
Bytom 242
Des Moines 223
Munich 201
Los Angeles 198
Nanjing 174
Guangzhou 172
New York 153
Dong Ket 146
Chicago 137
Dublin 123
Abidjan 121
Ho Chi Minh City 121
São Paulo 105
Shanghai 99
Milan 90
Hefei 88
Turku 81
Buffalo 80
Libreville 77
Shenyang 75
London 73
Dearborn 72
Managua 72
Panama City 71
Rome 71
Vienna 71
Dakar 67
Luanda 66
Baku 65
Hanoi 64
Amman 63
Kampala 63
Yerevan 62
Djibouti 59
Bamako 58
Hebei 58
Jinan 58
Nairobi 58
Nanchang 58
Nassau 58
Bishkek 57
Nouakchott 57
Phnom Penh 57
Praia 57
Tashkent 57
Castries 56
Cotonou 55
Vientiane 55
Accra 54
Riga 53
Tallinn 53
Warsaw 53
Montevideo 52
San José 52
Harare 51
Kigali 51
Andorra la Vella 50
Lima 50
Niamey 50
Nuremberg 49
Athens 48
Conakry 48
Dushanbe 48
Lusaka 47
Minsk 47
Noumea 47
Podgorica 47
Kinshasa 46
Willemstad 46
Antananarivo 45
Tirana 45
Baghdad 44
Reykjavik 44
Ulan Bator 44
Havana 43
Rio de Janeiro 43
Dar es Salaam 42
Lappeenranta 42
Chisinau 41
Totale 32.227
Salva come PNG Salva come JPEG
Nome #
Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence 461
DPP-4 inhibitors moderate the risk of genitourinary tract infections associated with SGLT2 inhibitors 244
Bone marrow macrophages contribute to diabetic stem cell mobilopathy by producing Oncostatin M. 238
NETosis delays diabetic wound healing in mice and humans 233
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 233
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 227
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs. 226
Phenotypic activation and pharmacological outcomes of spontaneously differentiated human monocyte-derived macrophages. 224
Loss of mitochondrial calcium uniporter rewires skeletal muscle metabolism and substrate preference 219
Diabetes-associated myelopoiesis drives stem cell mobilopathy through an OSM-p66Shc signaling pathway 217
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 214
Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes 214
Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes 207
NETosis is induced by high glucose and associated with type 2 diabetes. 205
Alternative Activation of Human Macrophages Is Rescued by Estrogen Treatment in Vitro and Impaired by Menopausal Status. 203
Carotid Plaque Calcification Predicts Future Cardiovascular Events in Type 2 Diabetes 201
Clinical Efficacy and Safety of Angiogenesis Inhibitors: Sex Differences and Current Challenges 201
A perspective on NETosis in diabetes and cardiometabolic disorders 200
Mitochondrial Calcium Uptake Is Instrumental to Alternative Macrophage Polarization and Phagocytic Activity 200
Clones of Interstitial Cells From Bovine Aortic Valve Exhibit Different Calcifying Potential When Exposed to Endotoxin and Phosphate 195
p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans 195
Cross-talk of healthy and impaired human tissues for dissection of disease pathogenesis 195
High temporal resolution detection of patient-specific glucose uptake from human ex vivo adipose tissue on-chip. 194
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 194
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial 193
Convenience versus Biological Significance: Are PMA-Differentiated THP-1 Cells a Reliable Substitute for Blood-Derived Macrophages When Studying in Vitro Polarization? 193
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 188
Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells 187
Acute effects of linagliptin on progenitor cells, monocyte phenotypes, and soluble mediators in type 2 diabetes 186
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 186
Circulating myeloid calcifying cells have anti-angiogenic activity via thrombospondin-1 overexpression 185
A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. 183
Cardiovascular actions of GLP-1 and incretin-based pharmacotherapy. 180
Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients. 179
Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial. 179
Diabetes Limits Stem Cell Mobilization Following G-CSF but not Plerixafor. 179
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. 177
Sarcoidosis is a Th1/Th17 multisystem disorder 177
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 177
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo 175
Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients 174
An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. 174
Use and effectiveness of dapagliflozin in routine clinical practice. An Italian multicenter retrospective study 172
Development of a multiphoton-multicolor and super-resolution STED microscope for in vivo experiments 172
Circulating Endothelial Progenitor Cells Are Reduced In Peripheral Vascular Complications of Type 2 Diabetes Mellitus 171
Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. 170
Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia 170
Endothelial progenitor cells as resident accessory cells for post-ischemic angiogenesis. 169
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. 168
Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study 168
Characterization of endothelial progenitor cells 166
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. 166
High confidence and sensitivity four-dimensional fractionation for human plasma proteome analysis. 166
Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1 164
Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients. 164
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study 164
Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures 164
An underlying principle for the study of circulating progenitor cells in diabetes and its complications. 163
Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy. 163
Interplay between gut microbiota and p66Shc affects obesity-associated insulin resistance 163
Downregulation of the Longevity-Associated Protein SIRT1 in Insulin Resistance and Metabolic Syndrome. Potential Biochemical Mechanisms 163
A perspective on sirtuins in the metabolic syndrome. 162
Bisdemethoxycurcumin and Its Cyclized Pyrazole Analogue Differentially Disrupt Lipopolysaccharide Signalling in Human Monocyte-Derived Macrophages 161
The p66(Shc) redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells. 160
Arrhythmogenic Cardiomyopathy Is a Multicellular Disease Affecting Cardiac and Bone Marrow Mesenchymal Stromal Cells 160
Diabetes induces p66(shc) gene expression in human peripheral blood mononuclear cells: Relationship to oxidative stress 159
Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice 159
Endothelial progenitor cells and the diabetic paradox. 159
The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications. 159
Synergistic Interactions Among Metabolic Syndrome Components and Homeostasis Model Assessment of Insulin Resistance in a Middle-Aged General Population over Time. 158
The peritoneum as a natural scaffold for vascular regeneration. 158
17beta-estradiol modulates monocyte heterogeneity and macrophage polarization 158
Number and function of endothelial progenitor cells as a marker of severity of diabetic vasculopathy. 157
At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways 156
Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis. 156
Impaired hemodynamic response to meal intake in insulin-resistant subjects: an impedance cardiography approach 156
Circulating CD34(+) cells, metabolic syndrome, and cardiovascular risk 155
The continuum of monocyte phenotypes: Experimental evidence and prognostic utility in assessing cardiovascular risk 155
Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine care 154
Hematopoietic and Nonhematopoietic p66Shc Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes 154
Peripheral blood CD34(+)KDR(+) endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population 153
Vascular smooth muscle cells and monocyte-macrophages accomplice in the accelerated atherosclerosis of insulin resistance states 152
Persistent reduction of circulating myeloid calcifying cells in acromegaly. Relevance to the bone-vascular axis 152
Inhibition of SGLT-2 rescues bone marrow cell traffic for vascular repair. Role of glucose control and ketogenesis 152
Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans. 151
Circulating Stem Cells Associate With Adiposity and Future Metabolic Deterioration in Healthy Subjects 150
At the crossroads of longevity and metabolism: The metabolic syndrome and lifespan determinant pathways 150
Two cases of statin-induced rhabdomyolysis associated with mononeuropathy. 149
Increased tissue endothelial progenitor cells in end-stage lung diseases with pulmonary hypertension. 149
Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy. 149
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration 149
Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice 148
Lung Ultrasound Patterns and Clinical-Laboratory Correlates during COVID-19 Pneumonia: A Retrospective Study from North East Italy 148
Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. 147
Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells 147
High Abundance Proteins Depletion vs Low Abundance Proteins Enrichment: Comparison of Methods to Reduce the Plasma Proteome Complexity 147
Effects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: A case-control study 147
Pharmacologic targeting of endothelial progenitor cells. 146
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. 146
Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. 146
Totale 17.752
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.561
article - articoli 158.019
book - libri 787
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 324
Totale 325.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.693 0 0 0 395 273 476 226 426 712 977 608 600
2021/20225.288 203 550 698 329 282 324 252 590 318 123 511 1.108
2022/20233.485 745 373 75 452 489 433 38 250 415 42 142 31
2023/20242.057 79 293 234 146 111 218 159 77 86 242 201 211
2024/20258.654 23 579 380 319 992 265 539 663 810 406 1.473 2.205
2025/202612.530 1.675 3.007 5.392 2.456 0 0 0 0 0 0 0 0
Totale 49.177